Global Companion Animal Ear Infection Treatment Market by Disease Type (Otitis Externa, Otitis Media) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global companion animal ear infections market was worth USD 531.2 million in 2020. It is expected to grow at 6.5% compound annual growth rate (CAGR), between 2021 and 2028. The market is growing due to the increased incidence of otitis externala in pets. Dechra Pharmaceuticals states that otitis externa or ear infections is the final diagnosis in 2% and 5% respectively of feline and canine consultations. Due to strict lockdown norms, veterinary clinics were not allowed to operate during the COVID-19 pandemic. This resulted in a decrease in the number of visits and a consequently, a negative impact on the market. The market showed a V-shaped recovery in the third quarter of 2020, largely due to the return of pet clinics and the ease of norms. According to IDEXX in the United States, clinic visits rose by 6% in the fourth quarter 2020 compared to the previous quarter. This is expected to increase market growth during the forecast period.

COVID-19 prohibited outdoor visits. However, otitis was still a top 10 claim for pet insurance in 2020, according to Trupanion (a U.S.-based pet insurance provider). Between March 1, 2020 and May 31, 2020, the company received approximately 6,000 otitis claims. The North American veterinary dermatology forum reported that primary care did not provide better results for otitis clinical signs.

The pet population will continue to grow, which is expected to lead to increased demand for veterinary care services and an increase in pet expenditures. The American Pet Products Association reported that the total U.S. pet industry spending was USD 103.6 billion in 2020. It is projected to rise to USD 110 billion in 2021. Between 1994 and 2020, veterinary care spending grew by 560%.

In the same way, industry players continue to try to improve their market position by implementing various strategies such as regional expansions, new product launches, partnership & cooperation, and so on. Bayer (Elanco), launched Neptra ear solutions in the U.K. in February 2020 to expand its geographical footprint. Vetoquinol had signed the global licensing agreement in December 2019 with Klox Technologies, but not China.

Product Insights

In 2020, the anti-bacterial product category held the largest revenue share at over 44%. Due to rising incidences of ear infections in pets, the segment will remain at the top throughout the forecast period. Otitis externa is the most common ear disease. This is due to a bacterial infection. According to a study published in 2019 by the Asian Pacific Journal of Tropical Biomedicine (APJTB), 91 of 122 canines tested positive for bacterial species.

This segment can be further divided into fluoroquinolones and aminoglycosides. The market leader was aminoglycosides, which are the most commonly used antibiotics in companion animals. The industry is constantly looking to expand its product range by launching new products. In April 2020, Virbac introduced Easoticotic suspension to treat canine otitis externa. The fastest CAGR is expected to be in the corticosteroids segment, which will grow from 2021 to 2028.

Insights on Disease Types

With a market share of more than 65%, the otitis externa segment dominated in 2020. The typical quadruped ear canal in pets can make infections difficult to spot and cause them to get worse if they aren't treated. The symptoms include reddening of the skin, swelling, itching, redness, increased discharge, head shaking, and scaly skin. Many studies have shown that allergy is the main cause of otitis externala (OE). AVMA estimates that 16.5% of dogs will experience OE or complications at some point in their lives. This could lead to more severe ear infections.

Otitis media type segment held a significant share in 2020. It is expected to grow further at the fastest CAGR between 2021 and 2028. Otitis media is a condition that affects the middle ear canal. It can be a secondary result in as many as 50% of chronic OE cases. Staphylococcus species is the most common cause of otitis media. Other bacteria include Pseudomonas and Proteus as well as Streptococcus and Streptococcus. Although rare in horses it can be dangerous and even become chronic if left untreated.

Mode of Administration Insights

In 2020, the highest revenue share was held by topical administration with over 53%. Topical products can be creams, creams or drops. Many times, topical ear medications can be sufficient to treat ear infections or inflammations. Companies are also launching new products within this market. In June 2019, Virbac introduced Cortavance, a topical corticosteroid spray, in India's 4 largest cities. This segment is expected to be the largest in the market during the forecast period.

Over the forecast period, the fastest CAGR is expected to be in the otic segment. There are many otic products on the market. EASOTIC Otic Solution from Virbacacts is a quick-acting, easy-to-use remedy. SYNOTIC Otic Solutions from Zoetis can be used to relieve inflammation and pruritus that are associated with chronic and acute otitis canine. It's formulated to relieve otitis externa-related bacterial, fungal, and inflammation infections. This increases the demand.

Information on Animal Types

With a market share of more than 45%, the dogs segment was the dominant animal type segment in 2020. Nationwide's 2020 study found that ear infections in dogs is the second most common medical condition to require veterinary care. The segment is also growing due to increased dog ownership in both developing and developed countries. According to the American Pet Products Association's 2019-202020 national survey of pet owners, dog ownership has increased by 10% over the previous year.

According to APPA, the U.S. spent a substantial amount on dog healthcare in 2020. This is in addition to all companion animals. This will also boost the segment's growth. The fastest expected CAGR for the cat animal type segment will be 6.5%, which is more than the average over the forecast period. This segment is experiencing a significant increase in health and hygiene concerns for cats. The younger generation, particularly millennials, is more concerned about the health and well-being of their pets.

Regional Insights

North America was the dominant market, with more than 49% of the total in 2020. Market growth is aided by the presence of large animal health companies. The introduction of veterinary information systems has allowed for real-time diagnosis. This will facilitate R&D and increase product development. The market is also being boosted by the increase in veterinarians and veterinary clinics. According to AVMA, there were approximately 118,624 vets in the U.S. by 2020.

Asia Pacific will be the fastest-growing region market during the forecast period. Asia Pacific's market growth is driven by rising adoption of pets, increasing health concerns and the prevalence of pet diseases. The region's market growth is also due to rising healthcare spending on animal health as well as veterinary services.

Market Share Insights & Key Companies

With many small and large industry players, the market is extremely competitive. To gain more market share, most companies concentrate on R&D. Acquisitions, mergers, and partnerships. Zoetis, for example, invests in R&D to create new products and increase its market share. After acquiring Bayer, Elanco increased its market penetration in August 2020. In August 2020, Elanco granted worldwide rights to Osurnia to Dechra pharmaceuticals. The following are some of the major players in the global companion pet ear infection treatment market:

• Zoetis

• Elanco

• Dechra Pharmaceuticals

• Merck & Co., Inc.

• Vetoquinol

• Penn Veterinary Supply, Inc.

• Virbac S.A.

• Ceva Sante Animale

• Vedco, Inc.

Up Market Research published a new report titled “Companion Animal Ear Infection Treatment Market research report which is segmented by Disease Type (Otitis Externa, Otitis Media), By Players/Companies Ceva Sant© Animale, Penn Veterinary Supply Inc, Elanco, Merck & Co Inc, Zoetis, Dechra Pharmaceuticals, Vedco Inc, Vetoquinol, Virbac SA”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Companion Animal Ear Infection Treatment Market Report Segments:

The market is segmented by Disease Type (Otitis Externa, Otitis Media).

Companion Animal Ear Infection Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Companion Animal Ear Infection Treatment Market

Overview of the regional outlook of the Companion Animal Ear Infection Treatment Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Companion Animal Ear Infection Treatment Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Companion Animal Ear Infection Treatment Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Otitis Externa

                2. Otitis Media

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Companion Animal Ear Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Companion Animal Ear Infection Treatment Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.